Docetaxel therapy for classic Kaposi's sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Docetaxel therapy for classic Kaposi's sarcoma

Published:2019-02-21 Issue:3 Volume:15 Page:181-182
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Hosokawa Yuna¹^ORCID,Kato Junji¹,Hida Tokimasa¹,Horimoto Kohei¹,Sato Sayuri¹,Sawada Masahide¹,Sasaki Hiroshi¹,Matsui Yoshiyuki¹,Handa Toshiya¹,Uhara Hisashi¹

Affiliation:

1. Department of DermatologySapporo Medical University School of Medicine Sapporo Japan

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13139

Reference5 articles.

1. Efficacy of docetaxel in disseminated classical Kaposi’s sarcoma

2. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection

3. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma

4. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma

5. Successful treatment of iatrogenic Kaposi's sarcoma with low-dose docetaxel therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Docetaxel;Reactions Weekly;2019-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP